Rock Creek Pharmaceuticals, Inc. (RCPIQ) financial statements (2020 and earlier)

Company profile

Business Address 2040 WHITFIELD AVENUE
SARASOTA, FL 34243
State of Incorp. DE
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments00423
Cash and cash equivalents00423
Receivables0 0 
Inventory, net of allowances, customer advances and progress billings  35
Inventory  35
Prepaid expense 1 
Disposal group, including discontinued operation00 0
Prepaid expense and other current assets1
Other undisclosed current assets0720
Total current assets:18929
Noncurrent Assets
Property, plant and equipment0001
Long-term investments and receivables  1 
Accounts and financing receivable, after allowance for credit loss  1 
Intangible assets, net (including goodwill)0001
Intangible assets, net (excluding goodwill)0001
Restricted cash and investments17   
Disposal group, including discontinued operation, noncurrent assets00
Deferred costs0   
Other undisclosed noncurrent assets0011
Total noncurrent assets:19123
TOTAL ASSETS:2091132
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities92223
Accounts payable53  
Accrued liabilities4923
Employee-related liabilities 3  
Settlement liabilities 7
Debt12  0
Due to related parties00  
Disposal group, including discontinued operation0102
Other undisclosed current liabilities (3)22
Total current liabilities:221947
Noncurrent Liabilities
Long-term debt and lease obligation80  
Long-term debt, excluding current maturities80  
Total noncurrent liabilities:80  
Total liabilities:302047
Stockholders' equity
Stockholders' equity attributable to parent(11)(11)725
Common stock0000
Additional paid in capital299292271256
Accumulated deficit(310)(303)(264)(232)
Total stockholders' equity:(11)(11)725
TOTAL LIABILITIES AND EQUITY:2091132

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues1 96
Revenue, net  96
Financial services revenue1   
Cost of revenue
(Cost of Goods and Services Sold)
 (0)(5)(4)
Other undisclosed gross profit  00
Gross profit:1(0)43
Operating expenses(11)(33)(37)(27)
Other undisclosed operating income (loss)(1)0  
Operating loss:(11)(33)(33)(25)
Nonoperating income (expense)5(1)(0)7
Other nonoperating income (expense)4(1)(0)7
Interest and debt expense(0)(0) (0)
Loss from continuing operations before equity method investments, income taxes:(7)(33)(33)(18)
Other undisclosed income from continuing operations before income taxes00 0
Loss from continuing operations:(7)(33)(33)(18)
Loss from discontinued operations(0)(5)  
Net loss:(7)(39)(33)(18)
Other undisclosed net income (loss) attributable to parent  0(5)
Net loss available to common stockholders, diluted:(7)(39)(33)(23)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(7)(39)(33)(18)
Comprehensive loss, net of tax, attributable to parent:(7)(39)(33)(18)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: